Universal Corporation’s CEO called Q3 FY2026 “solid performance.” The numbers told a different story, and investors punished the stock accordingly.
Universal Corporation (NYSE:UVV) reported its third fiscal quarter on February 9, 2026, and the headline miss was hard to spin. EPS came in at $1.35 against a consensus estimate of $1.92, a -29.69% miss. Net income fell 44.25% year over year to $33.25 million. Shares dropped more than 10% on the news.
The Oversupply Admission Hidden in Plain Sight
The most revealing thing CEO Preston Wigner said wasn’t buried. It was right there in his prepared remarks, framed as a positive:
“As market dynamics evolve toward oversupply, our long track record in sourcing and local expertise in our operating regions position us well to navigate the environment effectively and optimize results under a range of conditions.”
Wigner is telling you oversupply is already happening. Dark air-cured tobacco is already in oversupply with higher inventory write-downs, and tobacco sales volumes fell roughly 8% in the quarter. Wigner flagged this trajectory in Q1 FY2026, warning that flue-cured and burley crops were expected to increase roughly 25% and 45% respectively. The oversupply has now arrived.
The Ingredients Bet Isn’t Paying Off Yet
Universal has been building a plant-based ingredients business as a long-term diversification play. Q3 results show how early-stage that story remains. Wigner acknowledged the gap:
“Results for the quarter reflected market headwinds and higher fixed costs from the significant investments we have made. We remain focused on converting customer interest into sales and advancing the growth of our solutions-based portfolio.”
“Converting customer interest into sales” means interest exists, but not yet revenue. The ingredients segment swung to an operating loss in Q3, weighed down by higher fixed costs from an expanded production facility, soft consumer-packaged-goods demand, and tariff headwinds. Compare that to Q2 FY2026, when ingredients revenue was up 18% year over year. The reversal is sharp.
Liquidity and a New CFO
Wigner leaned on two positives: a refinanced credit facility and a leadership upgrade. Universal upsized its revolving credit facility by $250 million and extended maturity to December 2030, with approximately $595 million available. That matters given operating cash flow turned negative at -$58.04 million in Q3, down sharply from the prior year.
On the CFO front, Steven Diel takes over effective April 1, 2026. Diel previously served as CFO of the Ingredients segment and led over $350 million in acquisitions that established that business. Diel’s appointment moves a key architect of the ingredients strategy into the top finance role.
The stock trades around $52.95 with a dividend yield near 6.1% and a P/E around 12x. Wigner’s messaging is consistently optimistic, but the data shows two core businesses under simultaneous pressure. The tobacco oversupply he telegraphed for three quarters has arrived. The ingredients pivot hasn’t delivered.
Top Gaining Stocks
Top Losing Stocks